Curtis A. Pettaway

16.7k total citations · 2 hit papers
264 papers, 10.1k citations indexed

About

Curtis A. Pettaway is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Rheumatology. According to data from OpenAlex, Curtis A. Pettaway has authored 264 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Pulmonary and Respiratory Medicine, 121 papers in Surgery and 59 papers in Rheumatology. Recurrent topics in Curtis A. Pettaway's work include Prostate Cancer Treatment and Research (92 papers), Prostate Cancer Diagnosis and Treatment (77 papers) and Genital Health and Disease (76 papers). Curtis A. Pettaway is often cited by papers focused on Prostate Cancer Treatment and Research (92 papers), Prostate Cancer Diagnosis and Treatment (77 papers) and Genital Health and Disease (76 papers). Curtis A. Pettaway collaborates with scholars based in United States, United Kingdom and Canada. Curtis A. Pettaway's co-authors include Louis L. Pisters, Colin P. Dinney, Isaiah J. Fidler, Patricia Troncoso, Joel W. Slaton, Christopher J. Logothetis, Lance C. Pagliaro, Philippe E. Spiess, Hisanori Uehara and Corazon D. Bucana and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Curtis A. Pettaway

258 papers receiving 9.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Dutasteride on the Risk of Prostate Cancer

2010 750 citations Curtis A. Pettaway et al. profile →
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer

2017 455 citations John F. Ward, Curtis A. Pettaway et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Curtis A. Pettaway United States	52	3.5k	3.3k	2.9k	2.2k	2.0k	264	10.1k
Sam S. Chang United States	45	4.9k 1.4×	3.1k 0.9×	2.4k 0.8×	2.2k 1.0×	600 0.3×	209	9.9k
Maria De Santis Italy	46	6.2k 1.8×	2.2k 0.7×	2.5k 0.9×	1.8k 0.8×	983 0.5×	217	10.2k
Gary D. Steinberg United States	52	5.4k 1.5×	3.2k 1.0×	1.8k 0.6×	1.7k 0.8×	805 0.4×	295	9.2k
George N. Thalmann Switzerland	67	8.2k 2.3×	5.6k 1.7×	3.7k 1.3×	3.3k 1.5×	1.3k 0.6×	323	15.9k
Armen Aprikian Canada	48	3.0k 0.8×	4.2k 1.3×	2.0k 0.7×	2.2k 1.0×	930 0.5×	279	8.7k
Robert C. Flanigan United States	41	2.1k 0.6×	5.8k 1.8×	1.7k 0.6×	3.0k 1.4×	1.1k 0.5×	246	9.0k
Olivier Cussenot France	57	3.5k 1.0×	4.8k 1.5×	1.7k 0.6×	3.5k 1.6×	1.0k 0.5×	437	10.8k
Yves Fradet Canada	65	8.7k 2.5×	5.2k 1.6×	4.8k 1.7×	3.4k 1.5×	823 0.4×	376	16.1k
Paolo Gontero Italy	51	7.3k 2.1×	3.9k 1.2×	1.9k 0.6×	2.0k 0.9×	1.1k 0.6×	473	12.4k
Carl A. Olsson United States	52	2.3k 0.7×	5.5k 1.7×	1.4k 0.5×	2.2k 1.0×	2.2k 1.1×	236	9.8k

Countries citing papers authored by Curtis A. Pettaway

Since Specialization

Citations

This map shows the geographic impact of Curtis A. Pettaway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Curtis A. Pettaway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Curtis A. Pettaway more than expected).

Fields of papers citing papers by Curtis A. Pettaway

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Curtis A. Pettaway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Curtis A. Pettaway. The network helps show where Curtis A. Pettaway may publish in the future.

Co-authorship network of co-authors of Curtis A. Pettaway

This figure shows the co-authorship network connecting the top 25 collaborators of Curtis A. Pettaway. A scholar is included among the top collaborators of Curtis A. Pettaway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Curtis A. Pettaway. Curtis A. Pettaway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cho, Dalnim, Yisheng Li, Karen Basen‐Engquist, et al.. (2025). Couple-based lifestyle intervention for minority prostate cancer survivors: a randomized feasibility trial. Annals of Behavioral Medicine. 59(1).

Yu, Xiaoqing, Taylor Peak, Jasreman Dhillon, et al.. (2025). Progressive T cell exhaustion and predominance of aging tissue associated macrophages with advancing disease stage in penile squamous cell carcinoma. Scientific Reports. 15(1). 7703–7703. 3 indexed citations

Kouzy, Ramez, Lauren E. Colbert, Miao Zhang, et al.. (2025). Urethral Adenocarcinoma: A Rare Malignancy With Poor Oncologic Outcomes Despite Neoadjuvant Treatment and Consolidative Therapy. JU Open Plus. 3(3).

Zemp, Logan, et al.. (2024). Management of Bulky Inguinal and Pelvic Lymph Nodes. Urologic Clinics of North America. 51(3). 335–345. 1 indexed citations

Fang, Andrew M., Justin R. Gregg, Curtis A. Pettaway, et al.. (2024). Whole‐body MRI for staging prostate cancer: a narrative review. British Journal of Urology. 135(1). 13–21. 2 indexed citations

Morris, Van K., Amir A. Jazaeri, Shannon N. Westin, et al.. (2023). Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers. The Oncologist. 28(7). 618–623. 13 indexed citations

Ionescu, Filip, Houssein Safa, G. Daniel Grass, et al.. (2023). The Prognostic Role of Human Papillomavirus and p16 Status in Penile Squamous Cell Carcinoma—A Systematic Review. Cancers. 15(14). 3713–3713. 14 indexed citations

Bree, Kelly K., Patrick J. Hensley, & Curtis A. Pettaway. (2021). Germline Mutations in African American Men With Prostate Cancer: Incidence, Implications and Diagnostic Disparities. Urology. 163. 148–155. 5 indexed citations

Carmack, Cindy L., Nathan H. Parker, Wendy Demark‐Wahnefried, et al.. (2021). Healthy Moves to Improve Lifestyle Behaviors of Cancer Survivors and Their Spouses: Feasibility and Preliminary Results of Intervention Efficacy. Nutrients. 13(12). 4460–4460. 17 indexed citations

10.

Cho, Dalnim, Kathrin Milbury, Yue Liao, et al.. (2021). Study protocol: One plus one can be greater than two—Ecological momentary assessment for Black prostate cancer survivors and partners. PLoS ONE. 16(8). e0255614–e0255614. 2 indexed citations

11.

Hahn, Andrew W., Jad Chahoud, Matthew T. Campbell, et al.. (2021). Pembrolizumab for advanced penile cancer: a case series from a phase II basket trial. Investigational New Drugs. 39(5). 1405–1410. 37 indexed citations

12.

Chahoud, Jad, Frederico O. Gleber‐Netto, Priya Rao, et al.. (2021). Whole-exome Sequencing in Penile Squamous Cell Carcinoma Uncovers Novel Prognostic Categorization and Drug Targets Similar to Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 27(9). 2560–2570. 43 indexed citations

13.

Hensley, Patrick J., Kelly K. Bree, Charles C. Guo, et al.. (2021). Clinicopathological analysis and outcomes of inflammatory myofibroblastic tumours of the urinary bladder. British Journal of Urology. 130(5). 604–610. 3 indexed citations

14.

Hoffman, Richard M., Robert J. Volk, Brian F. Chapin, et al.. (2019). Impact of Multidisciplinary Counseling on Awareness of Prostate Cancer Treatment Options. International Journal of Radiation Oncology*Biology*Physics. 105(1). E442–E442. 1 indexed citations

15.

Williams, Stephen B., John W. Davis, Xuemei Wang, et al.. (2015). Neoadjuvant Systemic Therapy Before Radical Prostatectomy in High-Risk Prostate Cancer Does Not Increase Surgical Morbidity: Contemporary Results Using the Clavien System. Clinical Genitourinary Cancer. 14(2). 130–138. 14 indexed citations

16.

Cohen, Lorenzo, Patricia A. Parker, Luis M. Vence, et al.. (2011). Presurgical Stress Management Improves Postoperative Immune Function in Men With Prostate Cancer Undergoing Radical Prostatectomy. Psychosomatic Medicine. 73(3). 218–225. 53 indexed citations

17.

Gorlov, Ivan P., Kanishka Sircar, Hongya Zhao, et al.. (2010). Prioritizing genes associated with prostate cancer development. BMC Cancer. 10(1). 599–599. 30 indexed citations

18.

Cárdenas-Turanzas, Marylou, Catherine D. Cooksley, Ashish M. Kamat, Curtis A. Pettaway, & Linda S. Elting. (2008). Gender and age differences in blood utilization and length of stay in radical cystectomy: a population-based study. International Urology and Nephrology. 40(4). 893–899. 25 indexed citations

19.

Kamat, Ashish M., Samuel Huang, Carlos E. Bermejo, et al.. (2003). Total Pelvic Exenteration: Effective Palliation of Perineal Pain in Patients With Locally Recurrent Prostate Cancer. The Journal of Urology. 170(5). 1868–1871. 40 indexed citations

20.

Weinrich, Sally, Charmaine Royal, Curtis A. Pettaway, et al.. (2002). Interest in Genetic Prostate Cancer Susceptibility Testing Among African American Men. Cancer Nursing. 25(1). 28–34. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact